Archive: March 25, 2015

Health Diagnostic nears settlement on doc payments

Comments

Health Diagnostic Laboratory is nearing completion of a settlement agreement with the U.S. Justice Department related to an investigation into the lab’s payments to doctors for blood tests. The settlement agreement will include a denial of any wrongdoing by HDL, the laboratory, based in Richmond, Va., said in a statement. “We wish to make it clear that HDL Inc. has worked cooperatively with the Department of Justice since the inception…

Read More

FDA approves first biosimilar product : Zarxio

Comments

For Immediate Release March 6, 2015 Release The U.S. Food and Drug Administration today approved Zarxio (filgrastim-sndz), the first biosimilar product approved in the United States. Biological products are generally derived from a living organism. They can come from many sources, including humans, animals, microorganisms or yeast. A biosimilar product is a biological product that is approved based on a showing that it is highly similar to an already-approved biological…

Read More